CD40LG and neoplasm: Nineteen mice that were tumor free by bioluminescent imaging at day 50+ after initial luciferase-expressing A20.GL tumor challenge and m1928z-CD40L CAR T cell treatment were collected from three different previous experiments and separated into two cohorts (Supplementary Fig. 5D, E, F).